Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Unicycive Therapeutics Analyst Ratings and Price Targets | NASDAQ:UNCY | Benzinga
Unicycive Therapeutics Inc has a consensus price target of $6.07 based on the ratings of 7 analysts. The high is $9 issued by Piper Sandler on April 4, 2024. The low is $3 issued by Benchmark on November 22, 2024. The 3 most-recent analyst ratings were released by Guggenheim, HC Wainwright & Co., and HC Wainwright & Co. on April 21, 2025, April 11, 2025, and April 1, 2025, respectively. With an average price target of $7 between Guggenheim, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1163.31% upside for Unicycive Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
HC Wainwright & Co.
Benchmark
Piper Sandler
Noble Capital Markets
1calculated from analyst ratings
Analyst Ratings for Unicycive Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/21/2025 | Buy Now | 982.84% | Guggenheim | Vamil Divan73% | → $6 | Initiates | → Buy | Get Alert |
| 04/11/2025 | Buy Now | 1253.55% | HC Wainwright & Co. | Ed Arce58% | $7.5 → $7.5 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 1253.55% | HC Wainwright & Co. | Ed Arce58% | $4 → $7.5 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 621.89% | HC Wainwright & Co. | Ed Arce58% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 621.89% | HC Wainwright & Co. | Ed Arce58% | $4 → $4 | Maintains | Buy | Get Alert |
| 11/22/2024 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 11/14/2024 | Buy Now | 621.89% | HC Wainwright & Co. | Ed Arce58% | $2.5 → $4 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 351.18% | HC Wainwright & Co. | Ed Arce58% | $2.5 → $2.5 | Reiterates | Buy → Buy | Get Alert |
| 10/09/2024 | Buy Now | 351.18% | HC Wainwright & Co. | Ed Arce58% | $2.5 → $2.5 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2024 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 09/03/2024 | Buy Now | 351.18% | HC Wainwright & Co. | Ed Arce58% | $2.5 → $2.5 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 351.18% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $2.5 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 06/25/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 05/31/2024 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 05/29/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2024 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 04/04/2024 | Buy Now | 1524.26% | Piper Sandler | Yasmeen Rahimi55% | → $9 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 03/08/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 02/14/2024 | Buy Now | 982.84% | Noble Capital Markets | Robert LeBoyer47% | → $6 | Initiates | → Outperform | Get Alert |
| 12/19/2023 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2023 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 08/16/2023 | Buy Now | 712.13% | HC Wainwright & Co. | Ed Arce58% | $7 → $4.5 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 1163.31% | HC Wainwright & Co. | Ed Arce58% | → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 802.36% | EF Hutton | Elemer Piros54% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | Buy Now | 1163.31% | HC Wainwright & Co. | Ed Arce58% | $8 → $7 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 1343.78% | HC Wainwright & Co. | Ed Arce58% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 05/17/2023 | Buy Now | 1343.78% | HC Wainwright & Co. | Ed Arce58% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2023 | Buy Now | 802.36% | EF Hutton | Elemer Piros54% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 04/21/2023 | Buy Now | 441.42% | Benchmark | Bruce Jackson40% | $13 → $3 | Maintains | Speculative Buy | Get Alert |
| 04/03/2023 | Buy Now | 1343.78% | HC Wainwright & Co. | Ed Arce58% | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 4231.35% | EF Hutton | Elemer Piros54% | → $24 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 802.36% | EF Hutton | Elemer Piros54% | → $5 | Initiates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 1343.78% | HC Wainwright & Co. | Ed Arce58% | → $8 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 982.84% | Maxim Group | Jason McCarthy43% | $3 → $6 | Maintains | Buy | Get Alert |
| 11/28/2022 | Buy Now | 1343.78% | HC Wainwright & Co. | Ed Arce58% | $9 → $8 | Maintains | Buy | Get Alert |
| 06/08/2022 | Buy Now | 1524.26% | HC Wainwright & Co. | Ed Arce58% | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Unicycive Therapeutics (UNCY) stock?
The latest price target for Unicycive Therapeutics (NASDAQ:UNCY) was reported by Guggenheim on April 21, 2025. The analyst firm set a price target for $6.00 expecting UNCY to rise to within 12 months (a possible 982.84% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Unicycive Therapeutics (UNCY)?
The latest analyst rating for Unicycive Therapeutics (NASDAQ:UNCY) was provided by Guggenheim, and Unicycive Therapeutics initiated their buy rating.
When was the last upgrade for Unicycive Therapeutics (UNCY)?
There is no last upgrade for Unicycive Therapeutics
When was the last downgrade for Unicycive Therapeutics (UNCY)?
There is no last downgrade for Unicycive Therapeutics.
When is the next analyst rating going to be posted or updated for Unicycive Therapeutics (UNCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Unicycive Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Unicycive Therapeutics was filed on April 21, 2025 so you should expect the next rating to be made available sometime around April 21, 2026.
Is the Analyst Rating Unicycive Therapeutics (UNCY) correct?
While ratings are subjective and will change, the latest Unicycive Therapeutics (UNCY) rating was a initiated with a price target of $0.00 to $6.00. The current price Unicycive Therapeutics (UNCY) is trading at is $0.55, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
